We create content marketing for fertility and reproductive health companies that supports two truly different research needs, employer benefits evaluation and clinical patient research, without allowing one to overshadow the other or sacrificing medical accuracy.
Clinical content demands a medical review process that most content teams aren't prepared to manage
Content touching IVF success rates, treatment options, or medication protocols falls squarely into Google's stricter quality standards for medical content, and needs real clinical review, not just a marketing editor's pass, to be both accurate and trusted. Content produced without that review either underperforms in search or, worse, publishes something clinically misleading.
Employer benefits content and patient clinical content compete within the same site architecture and internal linking structure
Without deliberate content architecture, employer-facing pages about cost and ROI and patient-facing pages about treatment and outcomes get mixed together in navigation and internal linking, confusing both search engines about topical relevance and readers about which audience the page is written for.
Emotionally challenging search queries require content that respects the moment a person is experiencing
Searches like 'why did my IVF cycle fail' or 'signs of a chemical pregnancy' come from people in real distress, and content written purely for search volume without attention to tone can feel clinical, cold, or exploitative at exactly the wrong moment, damaging trust even if the information itself is accurate.
Content driven by search volume alone overlooks the specific questions HR buyers ask during evaluation
HR and benefits teams research fertility benefits using specific procurement language, PEPM cost, utilization modeling, network adequacy, that a content strategy built around broad consumer fertility topics tends to miss entirely, leaving a real content gap at the exact stage where an HR buyer is deciding whether to include the company in an RFP.
We create separate content architectures for employer-facing and patient-facing material, with distinct sections, navigation, and internal linking structures, so each content type strengthens topical relevance for its intended audience rather than weakening both. This also helps readers immediately identify which content was created for them.
For clinical content, we put a genuine medical review process in place with credentialed clinical staff or partners, rather than relying only on internal marketing review, so the content meets the accuracy and trust standards this subject requires and stands up to search engine quality expectations for medical information.
We approach emotionally difficult topics with the tone each moment calls for, being direct and honest about what's known without offering false reassurance or sounding clinically detached, because people searching these terms need information delivered with genuine care, not merely accurate information presented coldly.
For employer-facing content, we focus on the real procurement research performed by an HR or benefits buyer, PEPM cost benchmarks, utilization and outcomes data presented around a buyer's evaluation criteria, and network adequacy explanations, filling the gap that most consumer-focused fertility content strategies leave wide open.
A content strategy that views 'IVF success rates by age' and 'fertility benefit cost per employee' as one audience using different keywords will fail to fully serve either. They're different people completing different tasks on the same domain.
Our content marketing engagements operate as a 90-day sprint. Days 1-30 focus on auditing existing content, creating separate architectures for employer and patient content, and setting up the medical review process with your clinical stakeholders. Days 30-60 cover producing and publishing priority content across both tracks, with clinical material sent through review before publication. Days 60-90 evaluate early performance, adjust topic priorities according to what's actually generating qualified traffic, and transfer a repeatable production and review workflow to your team. Unlike a standard content marketing engagement, the architecture and review process are designed specifically for the divide between employer procurement research and clinical patient research.
The first month centers on the content audit and architecture, along with setting up the clinical review process, which calls for early coordination with whoever, internal medical staff or an external clinical advisor, will review clinical content moving forward. Weeks four through eight focus on initial content production for both employer and patient tracks, with review cycles incorporated into the production schedule instead of added afterward.
Days 60-90 evaluate early performance and adjust the content calendar using actual traffic and engagement data, while also delivering a workflow your team can manage independently. Most engagements last 4-6 months to develop enough published content and traffic history for clear performance signals to emerge across both audience tracks.
Clinical review capacity on your side is the most frequent bottleneck, making it important to identify and confirm that resource early in the engagement to remain on schedule.
If your fertility & reproductive health company needs content marketing leadership, we should talk.
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Most engagements cost $12,000 to $28,000 per month based on publishing volume across the employer and patient content tracks, as well as how much clinical review capacity exists internally versus needing to be sourced. Companies with existing clinical staff available to review content typically have lower costs than those that need an external clinical review partner added to the engagement.
Initial content is generally published within 45-60 days after the architecture and review process are established. Organic search traffic growth from new content typically takes 3-6 months to become meaningful, and longer for clinical topics competing with established medical publishers. Employer-facing procurement content often generates qualified engagement sooner because search volume is lower but more specific to intent.
We work closely with whoever manages clinical review, whether internal medical staff or an external advisor, to maintain production momentum without sacrificing accuracy. Marketing teams remain involved in prioritizing the content calendar and distribution. Weekly check-ins throughout active production keep both the employer and patient content tracks progressing in parallel, rather than letting one fall behind the other.
Most content agencies use a single content strategy and voice across an entire site. We develop truly separate architectures and review processes for employer procurement content and patient clinical content, because viewing them as one audience with different keywords fails to address what each reader actually needs from the page.
We measure organic traffic and ranking growth separately for employer-facing and patient-facing content tracks because they compete across different search environments and timelines. For employer content, we also monitor whether it is cited or referenced in actual sales conversations and RFP responses, indicating that the content is reaching buyers at the appropriate research stage.
This service is suited to companies serving both employer and patient audiences that currently rely on one undifferentiated content strategy, or companies with robust patient content but a significant gap in employer-facing procurement research materials. It is less valuable for a company serving just one audience type, where a single, more conventional content strategy is enough.
Tuesday, October 20, 2026
Frank Growth – Episode 242 – Why AI Slop Backfires with Nicole Cassese
Tuesday, June 16, 2026
Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy
Tuesday, October 13, 2026
Frank Growth – Episode 241 – What AI Still Can’t Do with Will Sartorius
Tuesday, August 25, 2026
Frank Growth – Episode 234 – Nobody Has The Playbook Yet with Dave Steer
Ready to unlock your growth?
Book Free Call